Neuberger Berman Increases Stake in ResMed Inc.

Investment firm grows position in medical equipment provider by 13.1% in third quarter.

Published on Mar. 8, 2026

Got story updates? Submit your updates here. ›

Neuberger Berman Group LLC increased its stake in ResMed Inc. (NYSE:RMD), a global medical device and cloud-connectivity company focused on sleep-disordered breathing and chronic respiratory conditions, by 13.1% during the third quarter. The institutional investor now owns 60,959 shares of the medical equipment provider's stock, valued at $16.69 million as of the most recent SEC filing.

Why it matters

ResMed is a leading provider of sleep apnea and respiratory care devices, an important and growing market as the global population ages. Neuberger Berman's increased investment signals confidence in ResMed's business and growth prospects.

The details

Neuberger Berman Group LLC purchased an additional 7,043 shares of ResMed during the third quarter, bringing its total position to 60,959 shares. ResMed's products, including continuous positive airway pressure (CPAP) and bilevel devices, masks and related accessories, are used by patients, clinicians and providers worldwide to treat sleep apnea and other respiratory disorders.

  • Neuberger Berman Group LLC increased its stake in ResMed during the third quarter of 2025.

The players

Neuberger Berman Group LLC

An investment management firm that owns a $16.69 million stake in ResMed Inc.

ResMed Inc.

A global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

Neuberger Berman's increased investment in ResMed reflects the growing importance of sleep apnea and respiratory care devices as the global population ages. ResMed's leadership position in this market makes it an attractive long-term investment for institutional investors.